• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Webinars and One-pagers 2025 Viral Hepatitis Surveillance Report Advocacy One-Pager

2025 Viral Hepatitis Surveillance Report Advocacy One-Pager

May 12, 2026

The 2025 Viral Hepatitis Surveillance Report advocacy one-pager highlights the critical role that surveillance infrastructure plays in understanding and responding to the viral hepatitis epidemic in the United States. It provides a snapshot, emphasizing that strong surveillance systems are foundational to viral hepatitis elimination efforts. Without reliable and standardized data, jurisdictions face major limitations in tracking disease burden, identifying disparities, monitoring outbreaks, understanding treatment needs, and directing resources where they are most needed. The report demonstrates that increased federal investment has improved staffing, planning, and surveillance activities across many jurisdictions, but capacity remains uneven and fragile.

The full report, developed by HepVu and NASTAD, tracks the progress jurisdictions have made in strengthening hepatitis surveillance capacity since CDC funding expanded in 2021, while also underscoring the significant challenges that remain.

Download Here: SSR Advocacy One-Pager

 

Download
Share Facebook Twitter Pinterest LinkedIn
Download
Share Facebook Twitter Pinterest LinkedIn
Share Facebook Twitter LinkedIn Email

Keep Reading

May 12, 2026

2025 Viral Hepatitis Surveillance Report Advocacy One-Pager

Read More

July 18, 2024

New Hepatitis C Prevalence Updates Webinar

Read More

June 4, 2024

Hepatitis A One-Pager: Estimating herd immunity thresholds for hepatitis A: A 16-state analysis to inform vaccination strategies among PWID

Read More

May 7, 2024

Surveillance Status Report: A One-pager on Staffing

Read More

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2026 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.